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Background: The aim of this study was to examine the trend in increasing life   expectancy 
in relation to heart attack and cardiac catheterization.
Methods: A retrospective study of very elderly patients over 90 years of age (study group) and 
between 70 and 79 years of age (control group) with myocardial infarction and acute coronary 
syndrome who underwent coronary angiography was conducted.
Results: A total of 1100 cardiac catheterizations were performed in the cardiac catheteriza-
tion laboratory of  Vinzentius-Hospital in Landau, Germany from 2007 to 2011. The number 
of coronary angiographies performed in patients aged over 90 years and those aged 70–79 
years was 36 and 354, respectively, during this same time period. No increase in the number of 
evidence-based therapy for coronary heart disease by cardiac catheterization was observed in 
the very elderly patients over this time period.
Conclusion: An increase in the number of patients aged over 90 years and a rise in heart attacks, 
as evaluated by coronary angiography, could not be found in this study.
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Introduction
An increase in life expectancy has been reported in developed countries and the result 
will be an aging population.1 A consequence of this development is an increase in 
heart attacks in older people.
Despite the extensive published information regarding the treatment of acute 
coronary syndrome (ACS), there are few data available for the guidance and evalu-
ation of ACS management in the elderly, since only a minority of published clinical 
trials include elderly patients.2 Even when elderly patients are enrolled in clinical trials, 
they typically account for a disproportionately small portion of the study population, 
and age-subset-specific results are often not reported.3,4 Indeed, patients older than 
75 years of age comprise only 9% of clinical trial populations, and only about 50% 
of trials enroll patients above the age of 75 years.5 Data guiding coronary reperfusion 
in elderly ACS patients are limited and consist mostly of subset analyses from major 
trials and retrospective studies.6
According to guidelines, patients with non-ST-elevation myocardial infarction 
(NSTEMI) and acute ST-segment elevation myocardial infarction (STEMI) on the 
electrocardiogram should undergo a primary percutaneous coronary intervention.7 
Although no age limit for this treatment is specified in the guidelines, older patients 
with myocardial infarction are less often treated with invasive treatment.8 The most 
common cause of death in developed countries is ischemic heart disease in patients 
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over 65 years of age.9 This is most evident in Europe, where 
the aging of the   population has led to an increase in coronary 
heart disease.10 This   current trend is expected to continue with 
the increase in life   expectancy.10 This study investigates the 
trend of increasing life expectancy in relation to myocardial 
infarction and left heart catheterization.
Methods
study groups
This study was retrospective, and examined patients 
aged 90–100 years (study group) with angina pectoris, 
NSTEMI, and acute STEMI on an electrocardiogram. 
These patients were compared with patients between 70 and 
79 years of age who had the same symptoms and diagnoses 
(control group) from 2007 to 2011. In total, 1100 patients 
were evaluated during this time period. All patients in this 
study underwent coronary angiography. The cardiovascular 
risk factors examined were elevated blood pressure, diabetes 
mellitus, hyperlipidemia, obesity, smoking, and a family 
history of cardiovascular disease. Comorbidities and the 
length of hospital stay of patients admitted to hospital were 
also compared between the two groups. All patients with 
myocardial   infarction were treated with a loading dose of 
aspirin (500 mg), clopidogrel (300 mg), and a single dose of 
heparin (5000 IU), followed by a typical daily dose of aspirin 
and clopidogrel. A major adverse cardiac event was defined 
as death, history of stroke, or myocardial infarction.
statistical analysis
The confidence interval of a proportion was   calculated given 
the necessary size of this study and results. The Kolmogorov–
Smirnov test was used to compare the length of the hospital 
stay. The survival rate for both groups was calculated using 
the Kaplan–Maier method and comparison of gender dis-
tribution among groups was calculated using the Kruskal–
Wallis test. Data were checked   afterwards for normality 
using the Kolmogorov–Smirnov test. A P value of ,0.05 
was considered statistically significant. Mean and   standard 
deviation (SD) were also calculated.
Results
Primary percutaneous coronary 
intervention
A total of 1100 left heart catheterizations were performed in 
this Vinzentius-Hospital in Landau, Germany from 2007 
to 2011. Only 36 (3.27%) patients over 90 years of age 
were treated by cardiac catheterization from 2007 to 
2011, whereas 354 (32.18%) patients aged 70–79 years 
underwent coronary angiography in the same time period. 
In 2007, 39 coronary angiographies were carried out, with 
four (10.26%) and six (15.38%) of them performed in the 
study and   control groups, respectively. In 2008, the number 
of invasive examinations significantly increased to 231. Eight 
(3.46%) and 81 (35.06%) patients in the study and control 
groups, respectively, underwent coronary angiography. In 
2009, 15 (4.63%) patients in the study group and 111 (34.26%) 
in the control group from a total of 324 invasive treatments 
underwent coronary angiography. A slight decline in numbers 
of coronary angiographies to a total of 283 was observed in 
2010, thus, seven (2.47%) patients in the study group and 89 
(31.45%) in the control group were examined. Finally, the 
number of invasive investigations decreased to 223 in 2011 
(Figure 1). This decrease was observed in both groups. Two 
(0.90%) patients in the study group and 67 (30.04%) in the 
control group were treated by coronary angiography.
Age and gender distribution
The mean age of the study and control groups was 
91.5 (SD ± 1.8) and 74.6 (SD ± 2.8) years, respectively. The 
oldest patient was a 97-year-old man. Among the 36 patients 
in the study group, 14 (38.89%) men and 22 (61.11%) women 
underwent cardiac catheterization, whereas 211 (59.60%) 
men and 143 (40.40%) women underwent the procedure in 
the control group (Figure 2). According to the Kruskal–Wallis 
test, significantly more women than men underwent cardiac 
catheterization in the study group, whereas more men than 
women underwent the procedure in the control group.
Clinical appearance
Most cases of 235 (60.26%) were ACS. Nine (3.83%) were 
in the study group, whereas 226 (96.17%) were in the control 
group. Meanwhile, 134 (34.36%) patients had NSTEMI, with 
25 (18.66%) patients and 109 (81.34%) in the study and control 
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Figure 1 The number of cardiac catheterizations in the two groups: 70 to 79 years 
of age and 90 to 97 years of age in 2007–2011.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
78
YayanClinical Interventions in Aging 2012:7
groups, respectively. At least 21 (5.38%) patients had STEMI: 
two (9.52%) in the study group and 19 (90.48%) in the con-
trol group. In the control group, coronary angiography was 
performed because of abnormal ergometry in four patients.
Cardiovascular risk factors
Among the 36 patients in the study group, 30 (83.33%) had 
hypertension, 18 (50%) diabetes, six (16.67%) hyperlipidemia, 
and four (11.11%) were obese. One patient smoked. Among the 
354 patients in the control group, 296 (83.62%) had hyperten-
sion, 194 (54.80%) diabetes, 159 (44.92%) hyperlipidemia, 64 
(18.08%) were obese, 54 (15.25%) had a nicotine habit, and 17 
(4.8%) had a positive family history for cardiovascular disease.
Coronary heart disease
A total of 271 (69.49%) patients in both groups had coronary 
heart disease. Of these, 30 (11.07%) and 241 (88.93%) were 
in the study and control groups, respectively. In contrast, 
only 95 (24.36%) patients had no coronary artery disease. 
Five (5.26%) of these patients were in the study group, while 
90 (94.74%) were in the control group. Nineteen (4.87%) 
patients in the control group and five (1.28%) in the study 
group had coronary atherosclerosis.
Length of hospital stay
The average length of the hospital stay was 12.6 (SD ± 8.154) 
days in the study group and 8 (SD ± 5.669) days in the control 
group. The Kolmogorov–Smirnov test showed that the normal 
distribution in the study and control groups was 4.566 and 
33.762, respectively, with a significant deviation of at least 
99% from a normal distribution.
Comorbidities
The accompanying diseases in the study group involved 
heart and circulatory (51 diagnoses), kidney (22), thyroid (9), 
lung (4), gastrointestinal (4), and electrolyte disturbances 
(2). Meanwhile, the comorbidities in the control group 
were heart and circulatory (298 diagnoses), kidney (99), 
gastrointestinal (47), lung (37), thyroid (31), electrolyte 
disturbances (29), infections (17), and neurological disorders 
(7) (Figure 3).
Major adverse cardiac event
In the study group, one patient had a history of stroke 
compared with 47 patients in the control group. Among 
the 36 patients in the study group, no deaths occurred, so the 
probability of survival using the Kaplan–Meier method was 
100% (95% confidence interval [CI]: 100%–100%). In the 
control group, 3/351 died, giving a probability of survival of 
99.15% (95% CI: 98.19%–100%).
Discussion
An increase in the number of coronary angiographies was 
observed in both groups; however, a continuous increase 
was not detected in this present study. From 2007 to 2011, 
∼10% of the angiographies in this study were performed 
in patients aged 90 years or older relative to the control 
group.
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Figure 2 The gender distribution of the two groups.
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Figure 3 The various comorbidities in the two groups over the last few years.   
(A) study group; (B) Control group.
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NSTEMI occurred most frequently in the study group, 
whereas ACS was more common in the control group. 
Elderly ACS patients are more likely to have comorbid 
conditions such as diabetes mellitus, renal insufficiency, 
cerebrovascular disease, and heart failure.11,12 Moreover, 
limited functional capacity and dementia are also more com-
mon within this group of patients, so that these factors must 
be taken into account in management decisions.11,12 Further, 
in a previous study by Tespili et al, elderly patients, who 
were primarily female, had more comorbidities and more 
extensive cardiovascular disease prior to stroke.13 In this 
current study, however, the cardiovascular risk factors dif-
fered only slightly between the two groups, but older patients 
in the study group had more comorbidities (Figure 3), while 
stroke and death was more common in the control group. 
The probability of survival was markably better in the 
study group. Finally, the study group had a higher propor-
tion of women than men.
According to recent studies, invasive therapy significantly 
improves the survival of elderly patients with acute myo-
cardial infarction.14 In this current study, the probability of 
survival was notably better among older elderly patients than 
younger ones. Patients with advanced age, pre-existing coro-
nary artery disease, prior stroke, pre-existing renal failure, 
obesity, NSTEMI, prior ACS, and presence of supraventricu-
lar arrhythmias were found to be significantly more likely to 
undergo conservative treatment.15 In-hospital mortality was 
significantly higher in conservatively treated patients.13 This 
trend of conservative treatment in elderly with myocardial 
infarction appears to continue, according to this study.
Elderly patients represent a substantial proportion of the 
population admitted to hospital with myocardial infarction, 
and receive less evidenced-based therapy.16 Further, age is an 
independent predictor of short- and medium-term mortality.16 
In addition, a significant decrease in the utilization rate of 
invasive diagnostic coronary angiography and increased in-
hospital mortality were observed as patient age increased.17 
Approximately 33% of all ACS episodes occur in patients 
over 75 years old and account for approximately 60% of 
overall mortality due to ACS.18–20 The incidence of ACS in 
the elderly is projected to increase due to advances in prior 
ACS treatment in an aging population.21,22
Conclusion
This study did not observe an increase in evidence-based 
therapy for coronary heart disease by cardiac catheterization 
in very elderly patients over recent years.
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